Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mayer

Showing results (221-230 of 1,854) with videos related to

Pageof 186
Sort By:
Current Opinion in HIV and AIDS|December 5, 2024
Why is roll-out of long-acting PrEP agents so slow?Rupa R Patel, Kenneth H Mayer
The Medical Clinics of North America|February 8, 2024
A Practical Approach to Sexually Transmitted Infection Screening for the Primary Care ClinicianKevin L Ard, Kenneth H Mayer
Drugs|March 1, 1985
Current guidelines on the use of antibacterial drugs in patients with malignanciesK H Mayer, O H DeTorres
The New England Journal of Medicine|February 28, 1985
Cost of antibiotic prophylaxis after penetrating abdominal traumaR E White, K H Mayer
The Journal of Infectious Diseases|April 29, 2016
Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough?Douglas S Krakower, Kenneth H Mayer
Nature Reviews. Urology|December 2, 2015
Infection in 2015: HIV protection with PrEP - implications for controlling other STIsDouglas S Krakower, Kenneth H Mayer
Scientific American|March 1, 1992
Women and AIDSK H Mayer, C C Carpenter
Rhode Island Medicine|September 1, 1993
AIDS in the '90s: increasing clinical challenges and constructive responsesK H Mayer, B A DeBuono
Berliner Und Munchener Tierarztliche Wochenschrift|June 1, 1976
[Listeriosis in a riding-horse stock]H Mayer, M Kinzler, E Sickel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Clinical infectious diseases and the evolving human immunodeficiency virus epidemicK H Mayer, S L Gorbach
Pageof 186

Showing results (221-230 of 1,854) with videos related to

Sort By:
Pageof 186
Current Opinion in HIV and AIDS|December 5, 2024
Why is roll-out of long-acting PrEP agents so slow?Rupa R Patel, Kenneth H Mayer
The Medical Clinics of North America|February 8, 2024
A Practical Approach to Sexually Transmitted Infection Screening for the Primary Care ClinicianKevin L Ard, Kenneth H Mayer
Drugs|March 1, 1985
Current guidelines on the use of antibacterial drugs in patients with malignanciesK H Mayer, O H DeTorres
The New England Journal of Medicine|February 28, 1985
Cost of antibiotic prophylaxis after penetrating abdominal traumaR E White, K H Mayer
The Journal of Infectious Diseases|April 29, 2016
Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough?Douglas S Krakower, Kenneth H Mayer
Nature Reviews. Urology|December 2, 2015
Infection in 2015: HIV protection with PrEP - implications for controlling other STIsDouglas S Krakower, Kenneth H Mayer
Scientific American|March 1, 1992
Women and AIDSK H Mayer, C C Carpenter
Rhode Island Medicine|September 1, 1993
AIDS in the '90s: increasing clinical challenges and constructive responsesK H Mayer, B A DeBuono
Berliner Und Munchener Tierarztliche Wochenschrift|June 1, 1976
[Listeriosis in a riding-horse stock]H Mayer, M Kinzler, E Sickel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Clinical infectious diseases and the evolving human immunodeficiency virus epidemicK H Mayer, S L Gorbach
Pageof 186